Book a free consultation
A no-obligation conversation with our care team, arranged through KPCIRC.
Book a consultationCompany · one vision
About OnKommon
We exist so that no treatment option is missed because the science was too complex, too scattered, or too expensive to reach.
01Why we exist
One vision
Because every life deserves every option.
We exist so that no treatment option is missed because the science was too complex, too scattered, or too expensive to reach.
Our long-term vision is a computational digital twin of every patient’s cancer: a living model in which every therapy can be explored before it is ever given. Everything we do today is a step toward that, and useful care in its own right along the way.
Image placeholder
The OnKommon team in New Delhi
02
The gap we were built to close
Comprehensive genomic testing has arrived. But for most patients the result is a dense report with no decision attached, no plan, and no one to help act on it. Often in a language they do not fully understand, recommending drugs they cannot afford.
Data to decision
We turn a variant list into a ranked, signed plan.
Decision to access
We map biosimilars, assistance programmes and schemes.
Access to action
A named navigator carries the plan into real life.
03
Two halves of one whole
OnKommon is the product, the intelligence and the technology. KPCIRC, our exclusive clinical partner, is the licensed clinical authority: tumour boards, sign-offs, second opinions, genetic counselling and patient navigation.
A licensed clinician is accountable. No machine decides.
OnKommon was born inside KPCIRC, the Kwatra Precision Cancer Institute and Research Centre, and remains in exclusive partnership with it. That origin is why our intelligence arrives wrapped in genuine clinical care rather than sold as software.
04
How we fit into your care
- Your teamYour oncologist leads
They make the clinical decisions.
- OnKommonWe read the tumour
And turn the data into a ranked, evidenced plan.
- KPCIRCA tumour board signs
Licensed clinicians review, author and take responsibility.
- YouYou receive the plan
With a regional-language summary and a navigator.
05Who founded this
Leadership
OnKommon was founded by Bharat Kwatra, MSc (Cancer Genomics), Founder and Managing Director. He takes part in KPCIRC molecular tumour board meetings, bringing a cancer-genomics perspective to case discussions.
He also offers a dedicated genomics interpretation and education consultation, helping patients and families understand what their molecular results mean and what to ask their treating team.
Before launch: Confirm the final leadership title before publishing.
Image placeholder
Founder portrait
06
Where we are
OnKommon operates from New Delhi. Wherever you are in the country, care is coordinated remotely by your named navigator, with sampling arranged locally.
New Delhiour base
Pan-Indiasampling coordinated locally
Regionallanguages for every summary
Take the next step
Three ways forward. Pick the one that fits today.
Begin Blueprint Care
Commission your decision report and a dedicated clinical team.
Explore Blueprint CareAsk on WhatsApp, free
Signal replies to your first question within four hours, at no cost.
Start with Signal